G
Germitec
Leading the way in chemical free and ultrafast automated high level disinfection for reprocessing ultrasound probes
About Germitec
Germitec specializes in providing UV-C high-level disinfection (HLD) solutions specifically designed for reprocessing non-lumen ultrasound probes. The company operates in the healthcare sector, focusing on infection prevention and control. Its primary clients include hospitals, clinics, and medical facilities that utilize ultrasound technology. Germitec's business model revolves around the sale and maintenance of its disinfection devices, which are chemical-free and eco-friendly, ensuring safety for both medical staff and patients. The company generates revenue through the direct sale of its products and ongoing service contracts. Germitec's technology is recognized for its simplicity, efficiency, and effectiveness, having won awards such as the Prix Galien for Best Medical Device. The market for Germitec's products is driven by the increasing need for stringent infection control measures, especially in the wake of global health concerns like COVID-19.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2005
- Headquarters
- Ivry-sur-Seine, France
- Employees
- 65
- Open positions
- 1
- Dealroom signal
- 69.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, observatoire industrial tech, DT and LS, observatoire healthtech, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2025 | $32M | $128M | Turenne Capital · Financiere Arbevel · Eurazeo · Kurma Partners | ↗ |
| EARLY VC✓Equity / VC | May 2022 | $12M | $48M | Kurma Partners · Turenne Capital · Financiere Arbevel | ↗ |
Growth signals
Latest recorded traffic for Germitec is 2.7K monthly website visits, up 125% over the last three months. Germitec's team declined 3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Kurma Partners
Turenne Capital- FAFinanciere Arbevel
Eurazeo
Other known investors3 additional known investors
Galia Gestion
NACo- VPVincent PRÊTET
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Germitec on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Germitec’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.